TLSI Stock Catalyst: TriSalus Life Sciences Granted FDA 510(k) Clearance for TriNav Advance Delivery Device

Sep 22, 2026 · 4:16pm ET

The clearance allows for the marketing of the device in the United States.

Max move

+45.6%

High of day $7.18

Sparker timei

4:16pm ET

TLSI · Sep 22, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its TriNav Advance Delivery Device. This clearance permits the company to market the device for use in the United States.

The TriNav Advance Delivery Device is designed to enhance the delivery of therapeutic agents directly to target tissues, improving treatment efficacy and patient outcomes. With a free float of 38,159,873 shares, TriSalus Life Sciences continues to expand its product offerings in the medical devices sector.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time TLSI sparks.

Download Sniper App →

Catch the next TLSI-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →